8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.92%
Revenue growth under 50% of 2127.T's 2.73%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.15%
Gross profit growth under 50% of 2127.T's 6.59%. Michael Burry would be concerned about a severe competitive disadvantage.
32.84%
EBIT growth above 1.5x 2127.T's 4.43%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
28.75%
Operating income growth above 1.5x 2127.T's 7.09%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
25.93%
Net income growth above 1.5x 2127.T's 7.01%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
25.93%
EPS growth above 1.5x 2127.T's 6.96%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
25.93%
Diluted EPS growth above 1.5x 2127.T's 6.96%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
142.00%
10Y revenue/share CAGR at 50-75% of 2127.T's 208.75%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
46.86%
5Y revenue/share CAGR 1.25-1.5x 2127.T's 36.11%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
31.11%
3Y revenue/share CAGR above 1.5x 2127.T's 10.20%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
182.37%
Net income/share CAGR 1.25-1.5x 2127.T's 126.94%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
44.64%
5Y net income/share CAGR above 1.5x 2127.T's 15.92%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
51.81%
3Y net income/share CAGR above 1.5x 2127.T's 27.70%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
304.14%
10Y equity/share CAGR 1.25-1.5x 2127.T's 243.01%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
79.56%
5Y equity/share CAGR above 1.5x 2127.T's 26.05%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.29%
Positive short-term equity growth while 2127.T is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
62.50%
3Y dividend/share CAGR of 62.50% while 2127.T is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-1.61%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-6.17%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-2.56%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
2.19%
Positive BV/share change while 2127.T is negative. John Neff sees a clear edge over a competitor losing equity.
11.12%
We have some new debt while 2127.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-1.84%
We cut SG&A while 2127.T invests at 5.53%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.